Microomics is a spin-off company specialized in providing high-quality metagenomics analysis. Our capacities comprise solutions directed to Bacterial, Fungal and Shotgun metagenomics profiling, as well as whole genome and transcriptome analyses. Team with us to address your challenging questions about the composition and function of the microbiota in the niche of your interest. We handle all steps, from experimental design advice, sample preparation, DNA extraction, to sequencing and custom bioinformatics-statistics analysis and interpretation.

Microomics has already built a strong portfolio of clients and projects in different areas of activity, including:

  • Health-Care – Functional diets monitoring. Resistome characterization. Monitoring dental pathogens (Odontological clinics). Microomics‘ cooperation with dental clinics to study the impact of interventions such as implants, and the use of new materials on the oral microbiome, as well as the appearance of risk microbiota related with dental and gum disease, etc.
  • Livestock farming and Agriculture – Pre and probiotics effect on animals. Detection of potential pathogens. Biofertilizers development. Soil fertility characterization. Microomics contributes to more sustainable livestock farming testing pre- or probiotics with the aim to enable the animals to grow healthier, and avoid or reduce the use of antibiotics in livestock farming. 
  • Consumer Goods Industry – Monitoring biofermentative products. Water quality product. Detection of relevant enzymatic functional activites. Microomics offers services to monitoring bacterial functional activities on biofermentative products, biomarkers detection and relevant enzymatic functional activities. Further, it plays an active role in international environmental studies, such as the microbial characterization of the Pacific coast in North America.
  • Research – Pre and probiotics assays. Biomarker detection. Human diseases characterization (Obesity, Diabetes, Crohn’s disease, etc). Microomics works with hospitals and national research groups to characterize the microbiome associated with diseases and evaluate the effect that treatments and interventions have on it. For example, the analysis of the intestinal microbiome to evaluate the effect of probiotics and specific diets to treat childhood obesity, or studying the evolution of the intestinal and pulmonary microbiome in patients hospitalized in intensive care units (ICU).